GSA CAPITAL PARTNERS LLP

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1362033 LONDON, X0

Position in LCTX

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$292,396

-$260,342 QoQ

Shares Held

185,061

-44.1% QoQ

Ownership

0.074%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

GSA CAPITAL PARTNERS LLP holds $101,563,069 across 163 Biotechnology names. LCTX ranks #100 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	3,831	$2,959,983
2	ARDX	Ardelyx, Inc.	473,061	$2,833,635
3	NTLA	Intellia Therapeutics, Inc.	178,301	$2,285,818
4	NUVB	Nuvation Bio Inc.	495,792	$2,126,947
5	RXRX	Recursion Pharmaceuticals, Inc.	669,568	$2,055,573
6	WVE	Wave Life Sciences Ltd.	282,719	$2,049,712
7	SRPT	Sarepta Therapeutics, Inc.	90,960	$1,979,289
8	IOVA	Iovance Biotherapeutics, Inc.	557,085	$1,955,368

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$292,396	185,061	-44.1%	Shares	Sole	2026-05-08
2025-12-31	$552,738	330,981	-50.7%	Shares	Sole	2026-02-06
2025-09-30	$1,133,746	670,856	-25.3%	Shares	Sole	2025-11-07
2025-06-30	$816,826	897,611	-4.2%	Shares	Sole	2025-07-22
2025-03-31	$421,601	936,892	+129.2%	Shares	Sole	2025-05-08
2024-12-31	$204,418	408,837	+339.5%	Shares	Sole	2025-02-07
2024-09-30	$84,659	93,032	+605.0%	Shares	Sole	2024-11-05
2023-06-30	$18,606	13,196	-72.9%	Shares	Sole	2023-08-14
2022-09-30	$54,949	48,628	-58.9%	Shares	Sole	2022-11-14
2022-06-30	$186,926	118,308	+63.2%	Shares	Sole	2022-08-09
2022-03-31	$111,659	72,506	-9.4%	Shares	Sole	2022-05-11
2021-03-31	$188,000	80,000	+426.6%	Shares	Sole	2021-05-10
2020-06-30	$13,216	15,191	—	Shares	Sole	2020-08-11
No filing history on record for this holder in this stock.